Double-blind, randomized, placebo-controlled evaluation of atropine to prevent vasovagal reaction during removal of femoral arterial sheaths

Bhola N. Rama, Syed M. Mohiuddin, Aryan N. Mooss, Anil K. Khemani, Kay L. Ryschon, B. Daniel Lucas, Daniel E. Hilleman

Research output: Contribution to journalArticle

1 Scopus citations


Study Objective. To evaluate the efficacy and safety of atropine in preventing vasovagal reactions (VVRs) during removal of femoral arterial sheaths after diagnostic left heart catheterization. Design. Prospective, double-blind, randomized, placebo-controlled study. Setting. University- affiliated, 450-bed teaching hospital. Patients. One hundred sixty-five patients undergoing left heart catheterization. Interventions. Eighty-eight patients were assigned to receive atropine 0.5 mg intravenously and 77 received placebo 5 minutes before sheath removal. Measurements and Main Results. The frequency of VVRs was significantly reduced in the atropine group compared with the placebo group, 2.3% and 10.4%, respectively (overall relative risk in the atropine group 0.22, 95% CI 0.12-0.41, p=0.03). Significant decreases in systolic (35.2 ± 5.8 mm Hg, p

Original languageEnglish
Pages (from-to)867-873
Number of pages7
Issue number5 I
Publication statusPublished - Sep 1997


All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this